OQS
AMRX icon

Occudo Quantitative Strategies’s Amneal Pharmaceuticals AMRX Stock Holding History

Occudo Quantitative Strategies’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Sell
97,376
-54,631
-36% -$749K 0.09% 304
2026
Q1 		$1.96M Buy
152,007
+123,895
+441% +$1.66M 0.11% 265
2025
Q4 		$354K Buy
+28,112
New +$322K 0.02% 463
2025
Q3 		– Sell
-45,143
Closed -$365K – 659
2025
Q2 		$365K Sell
45,143
-1,871
-4% -$14.1K 0.04% 418
2025
Q1 		$389K Buy
+47,014
New +$392K 0.05% 422
2024
Q3 		– Sell
-45,150
Closed -$287K – 690
2024
Q2 		$287K Sell
45,150
-125
-0.3% -$794 0.05% 476
2024
Q1 		$274K Buy
+45,275
New +$255K 0.05% 493
2023
Q4 		– Sell
-33,883
Closed -$143K – 784
2023
Q3 		$143K Sell
33,883
-86,553
-72% -$323K 0.02% 841
2023
Q2 		$373K Buy
120,436
+1,654
+1% +$3.52K 0.04% 662
2023
Q1 		$165K Buy
118,782
+57,271
+93% +$114K 0.02% 774
2022
Q4 		$122K Buy
61,511
+25,513
+71% +$57.2K 0.01% 832
2022
Q3 		$73K Buy
+35,998
New +$101K 0.01% 1065
2021
Q3 		– Sell
-31,893
Closed -$163K – 999
2021
Q2 		$163K Sell
31,893
-8,271
-21% -$47K 0.02% 745
2021
Q1 		$270K Buy
+40,164
New +$223K 0.06% 527

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Occudo Quantitative Strategies's AMRX Position: Q2 2026 in Review

Occudo Quantitative Strategies reduced its Amneal Pharmaceuticals (AMRX) stake by 36% in Q2 2026, selling an estimated $749K and leaving 97,376 shares worth $1.69M. The position accounts for 0.09% of the portfolio, ranked #304.

Occudo Quantitative Strategies first reported a position in AMRX in Q1 2021 and has held it in 14 quarters since. The position peaked at $1.96M in Q1 2026. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Occudo Quantitative Strategies held 97,376 shares of Amneal Pharmaceuticals worth $1.69M as of Q2 2026.
  • Occudo Quantitative Strategies sold 54,631 Amneal Pharmaceuticals shares in Q2 2026, an estimated $749K.
  • Amneal Pharmaceuticals made up 0.09% of Occudo Quantitative Strategies's portfolio in Q2 2026, its #304 holding.
  • Occudo Quantitative Strategies first reported a position in Amneal Pharmaceuticals in Q1 2021 and has held it in 14 quarters since.
  • Occudo Quantitative Strategies's Amneal Pharmaceuticals position peaked at $1.96M in Q1 2026.
  • 311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.